Grifols diagnostics

Grifols to acquire a Novartis diagnostics business unit for US$1,675 million.
Novartis has agreed to sell its blood diagnostics unit to the Spanish healthcare group Grifols for $1.
Americas office:Grifols Diagnostic Solutions Inc.

Grifols acquired the blood transfusion diagnostics unit fromin 2013 as a platform for global expansion.
The sale of the Novartis blood transfusion diagnostics unit enables us to focus more sharply on our strategic businesses while providing Grifols with a platform for global expansion, said Novartis CEO Joseph Jimenez in a statement.

Novartis AG agreed to sell a blood-transfusion diagnostics unit to Spanish health-care company Grifols SA for $1.
The acquisition will give critical mass and a significant U.

Spain-based Grifols to acquire Novartis blood transfusion diagnostics unit for USD 1.
Grifols has been working in the fields of transfusion, blood banking, protein therapeutics and laboratory analysis for more than 70 years.
Company SummaryIn unseren Servicelaboren stehen als besondere Dienstleistung hochqualifizierte Experten auf dem Gebiet der Immunhämatologie zur Verfügung.

MADRID (Reuters) - Spanish pharmaceuticals group Grifols said on Monday it would finance its $1.
As President of the Grifols Diagnostics Division, Carsten is responsible for the worldwide commercial operations of the business, which today provides a broad portfolio of blood collection, blood testing, and blood typing products as well as hemostasis and immunology testing platforms.